Does ACALABRUTINIB Cause Dyspnoea? 259 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 259 reports of Dyspnoea have been filed in association with ACALABRUTINIB (CALQUENCE). This represents 2.7% of all adverse event reports for ACALABRUTINIB.
259
Reports of Dyspnoea with ACALABRUTINIB
2.7%
of all ACALABRUTINIB reports
18
Deaths
139
Hospitalizations
How Dangerous Is Dyspnoea From ACALABRUTINIB?
Of the 259 reports, 18 (6.9%) resulted in death, 139 (53.7%) required hospitalization, and 5 (1.9%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ACALABRUTINIB. However, 259 reports have been filed with the FAERS database.
What Other Side Effects Does ACALABRUTINIB Cause?
Death (1,857)
Fatigue (536)
Headache (534)
Product dose omission issue (349)
Diarrhoea (320)
Fall (289)
Malignant neoplasm progression (285)
Contusion (270)
Pneumonia (244)
Asthenia (243)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which ACALABRUTINIB Alternatives Have Lower Dyspnoea Risk?
ACALABRUTINIB vs ACAMPROSATE
ACALABRUTINIB vs ACARBOSE
ACALABRUTINIB vs ACCUTANE
ACALABRUTINIB vs ACEBUTOLOL
ACALABRUTINIB vs ACECLOFENAC